Presentation THT 2025 SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli Presenter: Howard Herrmann February 12, 2025
Presentation THT 2025 Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR Presenter: Michael Brener February 12, 2025
Presentation THT 2025 The Percutaneous Approach: One Step at a Time… Presenter: Mark Reisman February 12, 2025
Presentation THT 2025 The HF Physician's Approach: GDMT - Give the Darn Medicines a Try! Presenter: Ryan Tedford February 12, 2025
Presentation THT 2025 The Surgical Approach: Fix 'Em All At Once! Presenter: Gilbert Tang February 12, 2025
Presentation THT 2025 Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis Presenter: Nicolas Van Mieghem February 12, 2025
Presentation THT 2025 Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR Presenter: Michael Brener February 12, 2025
Presentation THT 2025 Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI Presenter: JoAnn Lindenfeld February 12, 2025
Presentation THT 2025 Putting It All Together: A Case of TTVR Presenter: Karl-Philipp Rommel February 12, 2025
Presentation THT Abstracts 2025 Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization Presenter: Phuuwadith Wattanachayakul February 11, 2025
News Conference News ISC 2025 GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke Caitlin E. Cox February 11, 2025
News Daily News Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say Todd Neale February 11, 2025
Presentation THT 2025 Emerging Questions in the Face of Multiple Effective Therapies Presenter: Matthew Maurer February 11, 2025
Presentation THT 2025 Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease Presenter: Mazen Hanna February 11, 2025
Presentation THT 2025 Anti-Amyloid Therapy – Will Depleters Change the Game? Presenter: Scott Solomon February 11, 2025
Presentation THT 2025 Silencing TTR With Drugs or CRISPR: Benefits and Risks Presenter: Ahmad Masri February 11, 2025
Presentation THT 2025 Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More Presenter: Giada Bianchi February 11, 2025
Presentation THT 2025 Stabilizers for TTR Amyloidosis: Is One Better Than Another Presenter: Jan Griffin February 11, 2025
News Daily News High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada Michael O'Riordan February 10, 2025